Emergency Related News

Advocate Christ Medical Center

April 2007


Titration of Nitroglycerin IV

On the ED CHF standing orders, we have an option of using nitroglycerin paste or IV.  Nitroglycerin (NTG) is usually started at a dose of 10mcg/min.  The drug is then titrated every 5 minutes by 10mcg/min.  The goal for NTG is to titrate until you get a 20% drop in mean arterial pressure (MAP) from baseline.  The MAP is the average arterial pressure during a cardiac cycle.  It represents the perfusion pressure for the blood flow through the cardiovascular system.

The MAP is the number in parentheses on the monitor after the blood pressure.  You can also calculate the MAP by the following equation:

 

      (systolic pressure) + (diastolic pressure X 2)

MAP =           __________________________________

                                               3

 

To figure a 20% decrease in MAP:

MAP X 0.80 = goal MAP

The goal is to titrate NTG to that goal MAP and maintain it at that level.  If you drop below that number, then you would decrease the drip rate.

If you are using Nitroglycerin for indications other than CHF make sure you are aware of what the titration parameters are such as relief of chest pain or systolic blood pressure.  The maximum dose on our pumps is set at 200mcg/min.  Always make sure that Nitroglycerin tubing is used.

Several Drugs Withdrawn From the Market…

Zelnorm

The irritable bowel syndrome drug Zelnorm was voluntarily taken off the market because of possible cardiovascular risks.  A new safety analysis found a higher chance of heart attack, stroke, and worsening chest pain.

Pergolide

The company that manufactures and distributes Pergolide (dopamine agonist used for the treatment of Parkinson’s) decided to withdraw the drug from the market due to the potential for heart valve damage. Two new studies (published in The New England Journal of Medicine in January 2007) showed that patients with Parkinson’s disease who were treated with Pergolide (Permax) had an increased chance of serious damage to their heart valves when compared to patients who did not receive the drug.  

Tigan suppository

The FDA has ordered companies to stop manufacturing and distributing unapproved suppository drug products containing trimethobenzamide (Tigan) used to treat nausea and vomiting in adults and children. The reason for the withdrawal is due to the lack of evidence of effectiveness of the suppository form. The oral and injectable products are still available.

 

Go to fullsize image

CMC Drug Error Report …

 

Some examples of errors or near misses that have been reported by you:

 

ü      Insulin given IM instead of IV

ü      Antibiotic orders missed (7 hour delay)

ü      MAP not calculated correct for Nitroglycerin drip

ü      Order for Nafcillin 1.5gm, pharmacy dispensed 1g instead

ü      Urine sample mislabeled with wrong patient (chart was in wrong slot)

 

 

Please continue to report any error(s) you encounter or make, or any near miss.

 

Remember this is completely anonymous.

 

 

Just A Reminder…

 

Antibiotics that are part of the pneumonia protocol are all stocked in the omnicell.

 

Biaxin (clarithromycin) 250mg tablets

Erythromycin 500mg vials

Rocephin 1g vials and premixed bags

Avelox 400mg IV premixed bag

Cipro 400mg IV premixed bag

Clindamycin 600mg IV premixed bag

Zosyn 3.375g IV premixed bag

Doxycycline 100mg vials

 

 

 


Image Preview

April

4/2 Christine Kulstad, Brad Kurtyka, Evon Niezabitowski, Joanne Chocola

4/3 Yolanda Woods

4/5 Omar Sawlani

4/8 April Bisaga, Pam Colangelo

4/9 Evelyn Haynes

4/10 Barbara Zwicki

4/11 Amy Hansen, Laura Pratt

4/14 Salimah Muhammad

4/16 Robert Harwood, Angelina Larks, Sheryl Anderson

4/17 David Nash, Sally Heinzel

4/19 Helen Izzo, Mary Kowalewski

4/20 Megan McGuffage, Tammy Kristensen

4/22 Ejaaz Kalimullah

4/23 Karen Hunhoff

4/25 Donna Martin

4/26 Cara McGuire, Kate Murczek

4/27 Cheryl Hickey, Jolene Lorenz

4/28 Staci Sienkiewicz

4/29 Mary Kay Griffin

4/30 Melissa DiDomenico, Cindy Markunas

 

Image Preview

 

Erik Kulstad, MD – Top Peer Reviewer for Annals of Emergency Medicine

 

Welcome: Jim Jensen, PharmD (3-11)

 

Please forward any news or announcements via email or IBEX to Rolla Sweis.

 

Any questions or comments please send to:

Andrea Carlson, MD

acarlsonmd@comcast.net

Rohit Gupta, MD

rogu@alum.mit.edu

Rolla Sweis, PharmD

Rolla.Sweis@advocatehealth.com